Skip to main content
logo
Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
21.56
+0.89 (4.31%)
At close: Apr 20, 2026, 4:00 PM EDT
21.56
0.00 (0.00%)
After-hours: Apr 20, 2026, 4:00 PM EDT

Burning Rock Biotech Revenue

In the year 2025, Burning Rock Biotech had annual revenue of 539.57M CNY with 4.60% growth. Burning Rock Biotech had revenue of 126.32M in the quarter ending December 31, 2025, with 0.23% growth.

Revenue (ttm)
539.57M CNY
Revenue Growth
+4.60%
P/S Ratio
2.96
Revenue / Employee
800,546 CNY
Employees
674
Market Cap
232.13M USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025539.57M23.75M4.60%
Dec 31, 2024515.82M-21.61M-4.02%
Dec 31, 2023537.44M-25.80M-4.58%
Dec 31, 2022563.24M55.38M10.90%
Dec 31, 2021507.86M77.96M18.13%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Myriad Genetics824.50M
OPKO Health606.88M
Castle Biosciences344.23M
Fulgent Genetics322.67M
MDxHealth107.88M
FONAR106.03M
Prenetics Global92.39M
Biodesix88.50M
Revenue Rankings

BNR News

More News